相关实验视频
Updated: Jun 29, 2025

09:52
Trans-Tympanic Drug Delivery for the Treatment of Ototoxicity
Published on: March 16, 2018
9.4K
伊瓦卡夫托尔通过CFTR-Nrf2-HO1/NQO1通路减轻了 gentamicin 诱导的耳毒性
Rui Hu1,2, Fan Wu2,3,4, Yi-Qing Zheng1,2,3
1Shenshan Medical Center, Memorial Hospital of Sun Yat-Sen University, Shanwei, People's Republic of China.
Redox report : communications in free radical research
|April 2, 2024
概括
作为CFTR激活剂的ivacaftor通过减少氧化应激和亡来保护 gentamicin 诱导的耳毒性. 这表明有治疗氨基糖化物诱导的听力损失的潜力.
科学领域:
- 耳毒性研究研究
- 药物发现 药物发现
- 细胞生物学 细胞生物学
背景情况:
- 根他米辛是一种常见的耳毒药物,会导致听力损失.
- 氧化应激是 gentamicin 诱导的头发细胞死亡的一个关键因素.
- 目前对于这种听力损失没有有效的治疗方法.
研究的目的:
- 为了评估 ivacaftor 对 gentamicin 诱导的耳毒性影响.
- 为了阐明 ivacaftor 的保护作用的机制.
主要方法:
- 在试验室内耳扩展器模型.
- 肌蛋白7a染色用于毛细胞计数.
- 道测试用于细胞亡.
- 对于反应性氧物种 (ROS) 的DCFH-DA探针.
- 对于Nrf2通路蛋白质的西部斑.
主要成果:
- 甘他素诱导了头发细胞中的ROS积累和亡.
- 伊瓦卡夫托的预治疗减轻了珍塔米辛的耳毒作用.
- 伊瓦卡夫托增加了Nrf2,HO1和NQO1蛋白质的表达.
- Nrf2 抑制剂 ML385 消除了 ivacaftor 的保护作用.
结论:
- CFTR-Nrf2-HO1 / NQO1通路可以保护 gentamicin 耳毒性.
- 伊瓦卡夫托显示出治疗氨基糖化物诱导的听力损失的潜力.
相关概念视频
Ligand-Gated Ion Channel Receptor: Gating Mechanism
2.2K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.2K
GPCRs Regulate Adenylyl Cylase Activity
5.5K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.5K
Antiepileptic Drugs: Potassium Channel Activators
180
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
180
Desensitization and Tachyphylaxis
1.7K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
1.7K

